31 – 40 of 47
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2003
-
Mark
IVIG induces dose-dependent amelioration of ITP in rodent models [5] (multiple letters)
(
- Contribution to journal › Letter
- 2002
-
Mark
Recipient antigen-processing pathways of allogeneic platelet antigens : essential mediators of immunity.
(
- Contribution to journal › Scientific review
-
Mark
γ-globulins prepared from sera of multiparous women bind anti-HLA antibodies and inhibit an established in vivo human alloimmune response
(
- Contribution to journal › Article
- 2001
-
Mark
IVIg inhibits reticuloendothelial system function and ameliorates murine passive-immune thrombocytopenia independent of anti-idiotype reactivity
(
- Contribution to journal › Article
- 2000
-
Mark
Flow cytometric parameters for characterizing platelet activation by measuring P-selectin (CD62) expression : Theoretical consideration and evaluation in thrombin-treated platelet populations
(
- Contribution to journal › Article
-
Mark
Quantification of platelet activation status by analyzing P-selectin expression
(
- Contribution to journal › Article
-
Mark
Unique processing pathways within recipient antigen-presenting cells determine IgG immunity against donor platelet MHC antigens
(
- Contribution to journal › Article
- 1999
-
Mark
Extreme leukoreduction of major histocompatibility complex class II positive B cells enhances allogeneic platelet immunity
(
- Contribution to journal › Article
- 1997
-
Mark
Flow cytometric analysis of platelets from children with the Wiskott- Aldrich syndrome reveals defects in platelet development, activation and structure
(
- Contribution to journal › Article
- 1996
-
Mark
Recipient humoral immunity against leukoreduced allogeneic platelets is suppressed by aminoguanidine, a selective inhibitor of inducible nitric oxide synthase
(
- Contribution to journal › Article